TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Psyence BioMed Strengthens Strategic Partnership with PsyLabs Through USD $3,500,000 Follow-On Investment

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Jody Aufrichtig
Psyence BioMed Strengthens Strategic Partnership with PsyLabs Through USD $3,500,000 Follow-On Investment

Psyence BioMed made a $3.5 million follow-on investment in PsyLabs, a leading producer of psychedelic pharmaceutical ingredients, to secure a sustainable and ethical supply chain for its clinical research programs in mental health therapies.

Insights
BMLpJ   positive

First Investor Day in 14 years, recent earnings beat, and potential for optimistic outlook on consumer banking and economic trends


PBM   positive

Company is expanding strategic partnership, making significant investment, and positioning itself as a leader in psychedelic therapeutics research